ARTICLE | Clinical News
AstraZeneca Phase II Exanta stroke data
December 10, 2001 8:00 AM UTC
AstraZeneca (AZN; LSE:AZN) said that in an open-label continuation of its 125-patient Phase II SPORTIF II study, preliminary data showed that Exanta patients had 0.9 strokes and 0.4 transient ischemic...